Your browser doesn't support javascript.
loading
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro.
Walz, Annabelle; Duffey, Maëlle; Aljayyoussi, Ghaith; Sax, Sibylle; Leroy, Didier; Besson, Dominique; Burrows, Jeremy N; Cherkaoui-Rbati, Mohammed H; Gobeau, Nathalie; Westwood, Marie-Anne; Siethoff, Christoph; Gamo, Francisco-Javier; Mäser, Pascal; Wittlin, Sergio.
Afiliação
  • Walz A; Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland.
  • Duffey M; University of Basel, 4001 Basel, Switzerland.
  • Aljayyoussi G; Medicines for Malaria Venture, 1215 Geneva, Switzerland.
  • Sax S; Medicines for Malaria Venture, 1215 Geneva, Switzerland.
  • Leroy D; Liverpool School of Tropical Medicine, Centre for Drugs and Diagnostics, Liverpool L3 5QA, UK.
  • Besson D; Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland.
  • Burrows JN; University of Basel, 4001 Basel, Switzerland.
  • Cherkaoui-Rbati MH; Medicines for Malaria Venture, 1215 Geneva, Switzerland.
  • Gobeau N; Medicines for Malaria Venture, 1215 Geneva, Switzerland.
  • Westwood MA; Medicines for Malaria Venture, 1215 Geneva, Switzerland.
  • Siethoff C; Medicines for Malaria Venture, 1215 Geneva, Switzerland.
  • Gamo FJ; Medicines for Malaria Venture, 1215 Geneva, Switzerland.
  • Mäser P; Swiss BioQuant, 4153 Reinach, Switzerland.
  • Wittlin S; Swiss BioQuant, 4153 Reinach, Switzerland.
Pharmaceuticals (Basel) ; 16(2)2023 Jan 23.
Article em En | MEDLINE | ID: mdl-37009844
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça